The etiopathogenesis of Parkinson disease and suggestions for future research. Part I

Irene Litvan, Glenda Halliday, Mark Hallett, Christopher G. Goetz, Walter Rocca, Charles Duyckaerts, Yoav Ben-Shlomo, Dennis W. Dickson, Anthony E. Lang, Marie Francoise Chesselet, William J. Langston, Donato A. Di Monte, Thomas Gasser, Theo Hagg, John Hardy, Peter Jenner, Eldad Melamed, Richard H. Myers, Davis Parker, Donald L. Price

Research output: Contribution to journalReview articlepeer-review

89 Scopus citations


We are at a critical juncture in our knowledge of the etiology and pathogenesis of Parkinson disease (PD). It is clear that PD is not a single entity simply resulting from a dopaminergic deficit; rather it is most likely caused by a combination of genetic and environmental factors and, although there is extensive new information on the etiology and pathogenesis of PD that may advance its treatment, new syntheses of this information are needed. The first part of this two-part, state-of-the-art review by leaders in Parkinson research critically examines the field to identify where new knowledge and ideas might be helpful for treatment purposes. Topics reviewed in Part I include the definition of the disease, neuropathologic contributions, and epidemiologic, environmental, and demographic issues.

Original languageEnglish (US)
Pages (from-to)251-257
Number of pages7
JournalJournal of neuropathology and experimental neurology
Issue number4
StatePublished - Apr 2007


  • Lewy bodies
  • Parkinson disease
  • Synucleinopathies

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Neurology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience


Dive into the research topics of 'The etiopathogenesis of Parkinson disease and suggestions for future research. Part I'. Together they form a unique fingerprint.

Cite this